Stem cell and exosome therapy for kidney disease in Istanbul, Turkey
Individualized intravenous Wharton's jelly MSC and exosome protocols designed to modulate renal inflammation and fibrotic signaling alongside your ongoing nephrology care.
Understanding chronic kidney disease and how regenerative biologics support renal repair
Chronic kidney disease (CKD) is a progressive condition in which the kidneys' delicate filtering units—the nephrons, glomeruli, and peritubular capillary networks—face relentless metabolic, vascular, and inflammatory stress. Over time, persistent intrarenal inflammation, oxidative cellular injury, and TGF-beta-driven fibrotic scarring gradually replace healthy, working renal tissue with rigid extracellular matrix. For patients, this biological progression translates into declining estimated glomerular filtration rate (eGFR), rising serum creatinine, protein leakage in the urine, chronic fatigue, and constant concern over long-term kidney stability.
Intravenous Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) and WJ-MSC-derived exosomes are investigated for their ability to intervene across the core biological pathways driving renal decline. Once infused into the systemic circulation, WJ-MSCs sense inflammatory distress signals and release potent immunomodulatory and trophic factors—including hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), IGF-1, and IL-10—while shifting destructive M1 macrophages toward reparative M2 phenotypes and promoting regulatory T-cell (Treg) balance. Simultaneously, nanoscale WJ-MSC exosomes traverse the renal microvasculature to deliver anti-fibrotic microRNAs and protective proteins directly into stressed tubular epithelial cells and glomerular endothelial cells, helping calm oxidative injury, preserve capillary perfusion, and counter TGF-beta fibrotic remodeling.
At our Istanbul clinic led by Uzm. Dr. Cihan Bolat, you begin by sharing your nephrology diagnosis, serial laboratory trends (creatinine, eGFR, and urine albumin/protein ratios), and kidney ultrasound reports. Our medical team evaluates your longitudinal profile to design a stage-appropriate intravenous WJ-MSC and exosome protocol—working alongside your home nephrologist's medications to support remaining nephron vitality, vascular homeostasis, and daily systemic energy.
Reviewed by: Uzm. Dr. Cihan Bolat · Reviewed · Re-review due
What happens inside the body
What happens inside the kidneys in CKD—and how WJ-MSCs and exosomes respond
Four interconnected biological processes drive progressive nephron stress and declining filtration reserve—each representing a key therapeutic target for cellular and vesicular signaling.
Therapeutic objectives of our renal protocol
Our intravenous WJ-MSC and exosome protocols in Istanbul aim to support and protect the renal microenvironment while you maintain all blood-pressure, metabolic, and kidney-protective prescriptions with your home specialist.
Calming systemic and intrarenal pro-inflammatory cytokines while shifting macrophages from M1 toward reparative M2 states
Supporting glomerular and peritubular microvascular endothelial integrity via angiogenic factors (VEGF, HGF)
Delivering exosomal microRNAs and trophic signals to protect stressed renal tubular epithelial cells from oxidative injury
Countering pro-fibrotic TGF-beta signaling to help slow interstitial extracellular matrix scarring
Providing complete pre- and post-treatment lab documentation to track serial eGFR and urine ACR trends with your nephrologist
01
Glomerular & peritubular microvascular stress
Metabolic, hypertensive, or immune strain damages the delicate endothelial lining of glomerular capillaries and peritubular microvessels, causing capillary loss (rarefaction), chronic renal hypoxia, and breakdown of the filtration barrier.
Wharton's jelly MSCs and exosomes release angiogenic trophic factors—particularly VEGF, angiopoietins, and IGF-1—that support endothelial cell survival, stabilize glomerular filtration membranes, and help preserve microvascular oxygen delivery to working nephrons.
Activated pro-inflammatory M1 macrophages and T lymphocytes infiltrate the renal cortex and interstitium, releasing continuous waves of TNF-alpha, IL-6, and MCP-1 that injure healthy neighboring nephrons.
Through systemic immunomodulation, WJ-MSCs and their exosomes reprogram infiltrating macrophages from tissue-damaging M1 states toward reparative, anti-inflammatory M2 phenotypes while expanding regulatory T cells (Tregs) to calm intrarenal cytokine storms.
Proximal and distal renal tubular cells require immense mitochondrial energy to reabsorb solutes and maintain fluid balance; under chronic oxidative stress, these cells suffer mitochondrial dysfunction, apoptosis, and senescence.
WJ-MSC-derived exosomes deliver antioxidant enzymes, heat-shock proteins, and protective microRNAs directly into stressed tubular epithelial cells, helping restore mitochondrial energy metabolism, reduce cellular apoptosis, and support natural tubular repair.
Chronic tubular and vascular injury activates interstitial myofibroblasts via transforming growth factor-beta (TGF-beta) signaling, depositing dense collagen and fibronectin that permanently scar and obliterate functional nephrons.
Wharton's jelly MSCs secrete hepatocyte growth factor (HGF) and bone morphogenetic protein-7 (BMP-7) alongside anti-fibrotic exosomal microRNAs (such as miR-29 and miR-let-7 families) studied for antagonizing TGF-beta pathways and slowing fibrotic matrix accumulation.
Why regenerative medicine is investigated
Scientific rationale for Wharton's jelly MSCs and exosomes
Biological repair rationale
Interrupting the cycle of renal inflammation and fibrosis
Whether chronic kidney injury originates from diabetes, hypertension, or glomerular immune conditions, its progression is accelerated by a self-sustaining triad: microvascular capillary rarefaction, chronic macrophage-driven inflammation, and myofibroblast activation that lays down scar tissue across the renal interstitium.
While standard medications help manage blood pressure and intraglomerular pressure, regenerative biologics are studied specifically to quiet the intracellular inflammatory and pro-fibrotic cascades that continue to wear down viable nephrons.
Synergistic cellular & vesicular action
How IV WJ-MSCs and exosomes nourish stressed nephrons
Combining intravenous Wharton's jelly MSCs with purified WJ-MSC-derived exosomes engages both systemic immune regulation and direct parenchymal signaling. Live WJ-MSCs modulate circulating pro-inflammatory cytokines (such as TNF-alpha, IL-1beta, and IL-6) and secrete HGF and VEGF—two master growth factors known in renal biology for opposing TGF-beta fibrosis and protecting peritubular capillaries.
In parallel, nanoscale exosomes pass unobstructed through the glomerular and peritubular microcirculation, transferring regenerative microRNAs and antioxidant enzymes directly to fatigued tubular epithelial cells to support mitochondrial resilience and cellular repair.
Individualized clinical planning
Stage-aware protocols coordinated with your nephrologist
Because every patient's renal reserve, eGFR slope, electrolyte balance, and fluid tolerance are distinct, our medical team customizes every detail of your protocol before you travel. We review six to twelve months of serial kidney labs and imaging to establish your exact baseline trajectory.
Uzm. Dr. Cihan Bolat's team then calibrates your intravenous WJ-MSC cell count, exosome concentration, and infusion volume over a structured multi-day stay in Istanbul—ensuring seamless continuity with the kidney-protective medications managed by your home specialist.
Our treatment approach & administration routes
Our kidney disease biologics and administration routes
Following your medical evaluation, our team designs an individualized intravenous protocol using GMP-prepared Wharton's jelly biologics matched to your clinical stage and renal profile.
01
Intravenous Wharton's Jelly MSC Infusion
GMP-cultivated Wharton's jelly-derived mesenchymal stem cells are administered via slow, carefully monitored intravenous infusion. Possessing high proliferative vitality and potent secretome capacity, these cells interact with systemic immune networks to downregulate inflammatory cytokines, promote regulatory T-cell balance, and release continuous paracrine growth factors (HGF, VEGF, IGF-1) that support renal microcirculation and tubular resilience.
Role in your protocolCell dosage, carrier fluid volume, and infusion rate are individually calibrated to your body weight, CKD stage, and fluid-electrolyte status.
02
Intravenous WJ-MSC Exosome Administration
Purified extracellular vesicles (30–150 nm) harvested from Wharton's jelly MSCs circulate freely through narrow glomerular and peritubular capillaries without cellular trapping. Each exosome infusion delivers billions of lipid-bilayer vesicles carrying anti-fibrotic microRNAs, anti-inflammatory proteins, and mitochondrial-supportive signals directly to stressed renal tubular and endothelial cells.
Role in your protocolProvides concentrated nanoscale paracrine repair signaling without adding cellular volume to the circulation, making it an essential partner to MSC therapy.
03
Combined Cellular & Vesicular Signaling
Pairing intravenous WJ-MSCs with WJ-MSC-derived exosomes unites two complementary repair timelines: exosomes provide rapid intracellular uptake within renal parenchyma to quiet acute oxidative and fibrotic stress, while live WJ-MSCs establish sustained systemic immunomodulation and trophic factor secretion across the following weeks.
Role in your protocolOur medical team specifies the exact cell count, exosome concentration, and staged session sequence in your written treatment plan.
04
Individualized Dose & Nephrology Lab Coordination
Every renal protocol in Istanbul begins and concludes with targeted laboratory panels—evaluating serum creatinine, eGFR, blood urea nitrogen (BUN), electrolytes, albumin, CRP, and urinalysis—alongside vital-sign and fluid-balance monitoring during each outpatient infusion session.
Role in your protocolYou receive a comprehensive medical discharge summary detailing all administered biologics and lab results for seamless longitudinal follow-up with your home nephrologist.
What we aim to achieve
How we monitor renal repair signaling and clinical trajectory
Because a single creatinine reading can shift with hydration or diet, meaningful renal follow-up connects biological repair mechanisms to longitudinal laboratory slopes and systemic vitality over three, six, and twelve months.
01
Serial eGFR slope & creatinine stabilization
By calming intrarenal inflammation and supporting peritubular microcirculation, the primary clinical goal is helping slow the rate of eGFR decline and stabilizing serum creatinine trends over time. We compare your pre-treatment six-to-twelve-month eGFR trajectory against serial follow-up tests performed with your home nephrologist.
02
Urine albumin-to-creatinine ratio (ACR) & proteinuria
Protein or albumin leakage into the urine reflects stress along the glomerular capillary endothelium and podocyte filtration barrier. As angiogenic and anti-inflammatory signals from WJ-MSCs and exosomes support microvascular integrity, we track serial urine ACR or 24-hour protein measurements as markers of glomerular barrier stabilization.
03
Systemic inflammatory & metabolic balance
Chronic kidney disease is closely linked to systemic low-grade inflammation that accelerates vascular wear and fatigue. We monitor C-reactive protein (CRP), complete blood counts, serum albumin, and electrolyte stability (potassium, sodium, bicarbonate, calcium, phosphorus) before and after your Istanbul protocol.
When systemic uremic inflammation and oxidative stress are tempered, patients frequently focus on practical quality-of-life improvements—including steadier daytime energy, reduced physical exhaustion, clearer appetite, and stable blood-pressure control alongside their regular nephrology regimen.
How treatment is personalized
How our 6-step renal evaluation works
You begin by sending us your nephrology reports, serial blood and urine labs, and kidney imaging. Our medical team under Uzm. Dr. Cihan Bolat evaluates your longitudinal profile, designs an individualized IV WJ-MSC and exosome protocol where clinically appropriate, and explains the biologics, schedule, and costs before you travel to Istanbul.
Medical history & reports we request
Nephrology diagnosis, CKD stage, and medical history summary
Serial serum creatinine and eGFR results over the past 6 to 12 months
Urine albumin-to-creatinine ratio (ACR), urinalysis, or 24-hour urine protein results
Electrolytes (potassium, sodium, bicarbonate, calcium, phosphorus), CBC, HbA1c, and CRP
Recent kidney ultrasound report, biopsy findings if performed, and current medication list
Clinical suitability & timing checks
Acute kidney injury (AKI) or rapidly decompensating renal function requiring urgent hospital inpatient care
Severe fluid overload, uncontrolled hyperkalemia, or unstable cardiovascular disease
Active systemic or urinary tract infection until fully treated and cleared
Urgent need for dialysis access placement or acute transplant surgical intervention
What the patient journey looks like
From your first inquiry to individualized treatment in Istanbul
Reach out regarding your condition and share your medical history, diagnosis, imaging, and relevant lab reports via our secure form or WhatsApp.
02
Medical team evaluation & protocol design
Our medical team evaluates your records and, where clinically appropriate, develops an individualized Wharton's jelly MSC and exosome protocol.
03
Transparent explanation of protocol & costs
We explain the proposed treatment, specific biologics, administration routes, intended therapeutic objectives, stay timeline, and itemized costs.
04
Arrange treatment in Istanbul & follow-up
Review your individualized proposal, schedule your visit to Istanbul with private airport and clinic transfers, and continue with structured 1, 3, and 6-month follow-up.
2026 cost & protocol planning
Kidney disease stem cell and exosome therapy cost in Istanbul
After our medical team reviews your nephrology records and laboratory trends, you receive a clear, itemized written protocol detailing the proposed intravenous WJ-MSC and exosome doses, number of sessions, pre- and post-treatment blood work in Istanbul, and total cost.
For context, our 2026 systemic Wharton's jelly MSC and exosome programs generally range from $7,000 to $18,000 depending on total cell dosage, exosome concentration, and length of your multi-session schedule.
Total intravenous Wharton's jelly MSC count and WJ-MSC exosome concentration
Number of staged IV infusion sessions across your stay in Istanbul
Pre- and post-treatment renal, electrolyte, and inflammatory laboratory panels
Physician consultations, clinical infusion monitoring, and VIP airport/clinic transfers
Is my current CKD stage and eGFR trend suitable for an intravenous WJ-MSC and exosome protocol?
02
How do intravenous Wharton's jelly MSCs and exosomes target renal inflammation and fibrosis?
03
How many days will I need to stay in Istanbul for my infusions and laboratory checks?
04
How do I share my Istanbul treatment summary with my nephrologist back home?
Evidence & important considerations
Published clinical trials in mesenchymal kidney research
Early-phase randomized human trials evaluate the safety, tolerability, and renal biomarker trajectories of systemic mesenchymal stromal cell infusions in chronic kidney disease.
Randomized, placebo-controlled early-phase study in diabetic kidney disease
Finding
Demonstrated acceptable safety and tolerability while exploratory analyses tracked annual eGFR slope and inflammatory markers.
Limitation
Early-phase cohort size; measured GFR did not differ significantly from placebo over the initial window, highlighting the need for larger phase 2b/3 trials.
We administer GMP-prepared Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) and WJ-MSC-derived exosomes intravenously. Through systemic circulation, these biologics are studied for modulating pro-inflammatory cytokines, supporting renal microvascular endothelium, and tempering fibrotic signaling pathways.
Request Free Medical Evaluation
Begin a personalized treatment conversation with our medical team.
Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.
